MINUTE medical

Outpatient theranostic centre in Vienna & Salzburg, Austria — specializing in radioligand PSMA therapy for prostate cancer and PRRT for neuroendocrine tumors, plus molecular imaging (PSMA-PET/CT). Established radionuclides include Lutetium-177 and radium-223 dichloride; Actinium-225 and Terbium-161 are available under individual treatment access.